⌘K

Login Start Free

Home/Filings/4/0000950170-24-084182

4//SEC Filing

Henderson Molly 4

Accession 0000950170-24-084182

CIK 0001783183other

View on SEC.gov Company Profile

Filed

Jul 16, 8:00 PM ET

Accepted

Jul 17, 2:51 PM ET

Size

5.5 KB

Accession

0000950170-24-084182

Insider Transaction Report

Form 4

Period: 2024-07-15

Phathom Pharmaceuticals, Inc.PHAT

Henderson Molly

CFO and CBO

Transactions

Sale
Common Stock
2024-07-15$11.72/sh−4,325$50,689→ 99,447 total

Holdings

Common Stock
(indirect: By 401(k))
1,911.27

Footnotes (2)

[F1]Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.
[F2]Includes 1,009 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in July 2024.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Phathom Pharmaceuticals, Inc.

CIK 0001783183

Entity typeother

Related Parties

1

filerCIK 0001363812

Filing Metadata

Form type: 4
Filed: Jul 16, 8:00 PM ET
Accepted: Jul 17, 2:51 PM ET
Size: 5.5 KB

View on SEC.gov